En direct

Le Centre de Recherche en Cancérologie de Marseille fête ses 50 ans ! -

Apr 2016 European journal of endocrinology

Quality of life, clinical outcomes and safety of early prophylactic levothyroxine administration in patients with Graves’ hyperthyroidism undergoing radioiodine therapy: a randomized controlled study.


Taïeb D, Bournaud C, Eberle MC, Catargi B, Schvartz C, Cavarec MB, Faugeron I, Toubert ME, Benisvy D, Archange C, Mundler O, Caron P, Abdullah AE, Baumstarck K


While radioiodine therapy is commonly used for treating Graves’ disease, a prolonged and clinical hypothyroidism may result in disabling symptoms leading to deterioration of quality of life (QoL) of patients. Introducing levothyroxine (LT4) treatment in the early post-therapeutic period may be an interesting approach to limit this phenomenon.

Lire l‘article